Smartphone based biomarkers for bipolar disorder

We have shown that

1. Daily self-monitoring of affective symptoms using a Smartphone based system correlate with clinically rated depressive and manic symptoms.
2. Results from the first randomized controlled trial proved no overall effect on affective symptoms during a six months trial, but suggest that daily electronic self-monitoring using smartphones may reduce hypomanic symptoms but prolong depressive symptoms in patients with bipolar disorder.
3. Continuous Smartphone generated real-time data correlate with clinically rated depressive and manic symptoms.